Jeannette Y. Wick, RPh, MBA, FASCP

Articles by Jeannette Y. Wick, RPh, MBA, FASCP

The FDA approved Gilenya, a Novartis Pharmaceuticals' product for relapsing multiple sclerosis. The approved labeling indicates it reduces the frequency of clinical exacerbation and delays accumulation of physical disability.